Figure 4. SLC1A5 knockdown suppressed tumor growth in vivo.
(A-B) Tumors (shRNA-Control, n=7; shRNA-SLC1A5, n=7) were harvested after 20 days, imaged and measured. Results indicated targeting SLC1A5 significantly suppressed tumor growth. (C) SLC1A5 was detected in HGC-27 xenograft confirmed the efficiency of knockdown of SLC1A5.